Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-10

Clinical Trial Update: ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ProQuad (MMRV) with separate M-M-R II (MMR) and VARIVAX (varicella) vaccines in healthy children; the study is completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • M-M-R II (Measles, Mumps, and Rubella Vaccine)
  • ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)
  • Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2010-02-10